您的位置: 百康网 > 期刊 > 皮肤病学与性病学 > 《传染病的形成》 > 2006年 > 2006年5月第5期 > 正文
Novel Recombinant Norovirus in China
 本页关键词:Recombinant
2007-6-14 19:35:50

    The University of Tokyo, Tokyo, Japan
    Kunming Medical College, Kunming, People’s Republic of China
    Universitt Mainz, Mainz, Germany

    A fecal specimen was collected from an infant hospitalized with acute gastroenteritis in Kunming, China, in November 2004 and was tested for diarrheal viruses in a cooperative laboratory in Japan. The viral genome was extracted by using a Qiagen kit (Qiagen, Hilden, Germany). Polymerase chain reaction with specific primers resulted in the identification of astrovirus, rotavirus, sapovirus, adenovirus, and NoV genogroup I (GI) and GII (3). NoV polymerase was also amplified to identify recombinant NoV with primers Yuri22F and Yuri22R (4). Products were sequenced directly, and sequence analysis was performed by using ClustalX and SimPlot.

    The fecal specimen was positive for NoV GII. The Figure shows that the 146/Kunming/04/China sequence clustered into the distinct GII genotype 7 (Leeds/90/UK cluster). 146/Kunming/04/China was classified into the Saitama U4 cluster (GI/6) when polymerase-based grouping was performed. Altogether, 146/Kunming/04/China was expected to be the recombinant NoV with GII/7 capsid and GII/6 polymerase.

    To eliminate the possibility of co-infection with 2 different NoV genotypes, to localize the potential recombination site, and to clarify a possible recombination mechanism, the ORF1/ORF2 overlap and flanking polymerase and capsid regions of 146/Kunming/04/China was amplified with primers Yuri22F and GIISKR to produce a 1,158-bp amplicon (3,4). When the sequence of 146/Kunming/04/China was compared with that of Saitama U4 by using SimPlot, a recombination site was found at the ORF1/ORF2 overlap. Before this junction, 146/Kunming/04/China and Saitama U4 were homologous. After the ORF1/ORF2 overlap, however, the homology was notably different. SimPlot showed a sudden drop in the nucleotide identity for 146/Kunming/04/China. ClustalX showed that 146/Kunming/04/China shared a high identity (93%) in the polymerase region and a low identity (78%) in the capsid region with Saitama U4. In contrast, high identity (95%) in the capsid region was found between 146/Kunming/04/China and Leeds/90/UK. Since Leeds/90/UK polymerase was not available in GenBank, the polymerase homology between 146/Kunming/04/China and Leeds/90/UK was unknown. Polymerase of 146/Kunming/04/China was almost identical with that of Saitama U4, but the capsids of 146/Kunming/04/China and Leeds/90/UK were distinctly different from that of Saitama U4. This genetic pattern of 146/Kunming/04/China implied a novel, naturally occurring recombinant NoV with GII/7 capsid and GII/6 polymerase.

    RNA recombination is a mechanism for virus evolution (5). Literature documenting recombination in NoV is fairly rich, but none is from China (6). Therefore, 146/Kunming/04/China was not only the first but also the first recombinant NoV from China. This isolate shared the closest sequences of polymerase and capsid with Saitama U4 and Leeds/90/UK, respectively. Strain Saitama U4 was detected in 1997 in Japan (7), whereas strain Leeds/90/UK was detected in 1990 in the United Kingdom (8). Quite possibly, Saitama U4 and Leeds/90/UK were parental strains of 146/Kunming/04/China. However, the distant geographic relationship of these strains obscured evidence of where and when the recombination event occurred. This phenomenon also suggested that these parent strains or this progeny strain might be more prevalent than is often assumed.

    Recombination depends on various immunologic and intracellular constraints. Recombinant viruses are all alike in that they successfully pass through 5 stages: 1) successful co-infection of a single host, 2) successful co-infection of a single cell, 3) efficient replication of both parental strains, 4) template switching, and 5) purifying selection (9). In this study, 146/Kunming/04/China was recovered from a patient with diarrhea, fever, and vomiting. This observation indicated that this strain theoretically fulfilled all prerequisites for recombination.

    The NoV capsid is predicted to be well suited for genotype classification (10). In this study, 146/Kunming/04/China belonged to 2 distinct genotypes, 7 and 6, by capsid- and polymerase-based groupings, respectively. Moreover, the recent demonstration of recombination in an increasing number of NoVs suggests that it is a more widespread event than was previously realized. Consequently, the phylogenetic classification of NoV on the basis of on capsid sequence is questionable. We suggest that classification of NoV strains should rely on not only capsid sequence but also polymerase sequence.

    In conclusion, our results described the genetic characterization of novel, naturally occurring recombinant NoV and increased evidence for the worldwide distribution of recombinant NoV. This report is the first to describe acute gastroenteritis caused by recombinant NoV in China and warns of the threat it poses.

    This study was supported by grants-in-aid from the Ministry of Education and Sciences and the Ministry of Health, Labor and Welfare, Japan. This study was also supported by the Heiwa Nakajima Foundation, the Mishima-Kaiun Foundation, and the Sumitomo Foundation, Japan.

    References

    Lopman BA, Brown DW, Koopmans M. Human caliciviruses in Europe. J Clin Virol. 2002;24:137–60.

    Jiang X, Matson DO, Ruiz-Palacios GM, Hu J, Treanor J, Pickering LK. Expression, self-assembly, and antigenicity of a Snow Mountain agent-like calicivirus capsid protein. J Clin Microbiol. 1995;33:1452–5.

    Phan TG, Nguyen TA, Yan H, Yagyu F, Kozlov V, Kozlov A, et al. Development of a novel protocol for RT-multiplex PCR to detect diarrheal viruses among infants and children with acute gastroenteritis in Eastern Russia. Clin Lab. 2005;51:429–35.

    Saito H, Saito S, Kamada K, Harata S, Sato H, Morita M, et al. Application of RT-PCR designed from the sequence of the local SRSV strain to the screening in viral gastroenteritis outbreaks. Microbiol Immunol. 1998;42:439–46.

    Lai MM. RNA recombination in animal and plant viruses. Microbiol Rev. 1992;56:61–79.

    Bull RA, Hansman GS, Clancy LE, Tanaka MM, Rawlinson WD, White PA. Norovirus recombination in ORF1/ORF2 overlap. Emerg Infect Dis. 2005;11:1079–85.

    Katayama K, Shirato-Horikoshi H, Kojima S, Kageyama T, Oka T, Hoshino F, et al. Phylogenetic analysis of the complete genome of 18 Norwalk-like viruses. Virology. 2002;299:225–39.

    Green J, Vinje J, Gallimore CI, Koopmans M, Hale A, Brown DW, et al. Capsid protein diversity among Norwalk-like viruses. Virus Genes. 2000;20:227–36.

    Worobey M, Holmes EC. Evolutionary aspects of recombination in RNA viruses. J Gen Virol. 1999;80:2535–43.

    Kageyama T, Shinohara M, Uchida K, Fukushi S, Hoshino FB, Kojima S, et al. Coexistence of multiple genotypes, including newly identified genotypes, in outbreaks of gastroenteritis due to norovirus in Japan. J Clin Microbiol. 2004;42:2988–95.



查询更多Recombinant相关信息在本站>>

  

《传染病的形成》2006年5月第12卷第5期 

评论】【打印】【 】【关闭
相关文章
Phase I Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With B-Cell Malignancies
Novel Recombinant Sapovirus, Japan
High levels of IgG class antibodies to recombinant HSP60 kDa of Yersinia enterocolitica in sera of patients with uveitis
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
The Reduced Folate Carrier Gene Is a Novel Selectable Marker for Recombinant Protein Overexpression
Expression, Pharmacological Profile, and Functional Coupling of A2B Receptors in a Recombinant System and in Peripheral Blood Cells Using a Novel Selective Antagonist Radioligand, [3H]MRE 2029-F20
Structural Features of the Glutamate Binding Site in Recombinant NR1/NR2A N-Methyl-D-aspartate Receptors Determined by Site-Directed Mutagenesis and Molecular Modeling
Is recombinant activated factor VII useful for intractable bleeding after cardiac surgery
Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke
Potential Applicability of Recombinant Factor VIIa for Intracerebral Hemorrhage